Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Black seed extract shows promise for metabolic syndrome in midlife women

NCT ID NCT07013058

Disease control Sponsor: Liaquat University of Medical & Health Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a black seed extract (Nisatol®) in 50 perimenopausal women with metabolic syndrome, a cluster of conditions like high blood sugar and blood pressure. Over 4 months, researchers measured changes in blood sugar, cholesterol, blood pressure, and menopausal symptoms. The goal was to see if the extract could improve these health markers and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Jun 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Perimenopausal women aged 40-60 years * Presence of climacteric (menopausal) symptoms * Diagnosis of metabolic syndrome, defined as alteration of at least 3 of the following: * Systolic blood pressure ≥130 mmHg and/or diastolic ≥85 mmHg * HDL cholesterol \<50 mg/dL * Triglycerides ≥150 mg/dL * Fasting blood glucose ≥100 mg/dL * Uricemia \>7 mg/dL Exclusion Criteria: * Use of hormone replacement therapy (HRT) * Presence of neoplastic diseases * Presence of liver disease, kidney failure, or diabetes mellitus * Drug or alcohol abuse * Known hypersensitivity to Nigella sativa or any formulation component

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Elevated blood pressure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome hypertensive disorder metabolic syndrome X

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Elevated blood pressure Metabolic syndrome

Contacts and locations

Locations

  • ASL Frosinone, Dipartimento di Prevenzione,

    Frosinone, 03100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.